Effects of phenobarbital on the biliary excretion of aflatoxin P ₁-glucuronide and aflatoxin B₁-S-glutathione in the rat

References

• Baars A. J., Jansen M., Breimer D. D. The influence of phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxn on glutathione-S-transferase activity of rat liver cytosol. Biochemical Pharmacology 1978; 27: 2487–2494
   PubMed Web of Science ®Google Scholar
• Bassir O., Osiyemi F. Biliary excretion of aflatoxin in the rat after a single dose. Nature 1967; 215: 882
   PubMed Web of Science ®Google Scholar
• Castegnaro M., Hunt D. C., Sansone E. B., Schuller P. L., Siriwardana M. G., Telling G. M., Van Egmond H. P., Walker E. A. Laboratory decontamination and destruction of aflatoxins B₁, B₂, G₁, G₂ in laboratory wastes. IARC Publications. 1981; 1–59, No. 37
   Google Scholar
• Chen J., Geotchius M. P., Campeeli T. C., Combs G. F., Jr. Effects of dietary selenium and vitamin E on hepatic mixed-function oxidase activities and in vivo covalent binding of aflatoxin B in rats. Journal of Nutriticn 1982; 112: 324–331
   PubMed Web of Science ®Google Scholar
• Degen G. H., Neumann H. G. The major metabolite of aflatoxin B1 in the rat is a glutathione conjugate. Chemico-Biological Interactions 1978; 22: 239–255
   PubMed Web of Science ®Google Scholar
• Degen G. H., Neumann H. G. Differences in aflatoxin B1-susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1 -epoxide. Carcinogenesis 1981; 2: 299–306
   PubMed Web of Science ®Google Scholar
• Emerole G. O. Excretion of aflatoxin B1 as a glutathione conjugate. European Journal of Drug Metabolism and Pharmacokinetics 1981; 6: 265–268
   PubMedGoogle Scholar
• Emerole G. O., Neskovic N., Dixon R. L. The detoxication of aflatoxin B1 with glutathione in the rat. Xenobiotica 1979; 9: 737–743
   PubMed Web of Science ®Google Scholar
• Essigmann J. M., Croy R. G., Madzan A. M., Busby W. F., Jr., Reinhild V. N., Buchi G., Wogan G. N. Structural identification of major DNA adduct formed by aflatoxin B1 in vitro. Proceedings of the National Academy of Sciences of the USA 1977; 74: 1870–1874
   PubMed Web of Science ®Google Scholar
• Essigmann J. M., Croy R. G., Bennett R. A., Wogan G. N. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. Drug Metabolism Reviews 1982; 13: 581–602
   PubMed Web of Science ®Google Scholar
• Garner R. C. Microsome-dependent binding of aflatoxin B1 to DNA, RNA, polyribonucleotides and protein, in vitro. Chemico-Biological Interactions 1973; 6: 125–129
   PubMed Web of Science ®Google Scholar
• Garner R. C. Reduction in binding of 14C-aflatoxin B1 to rat liver macromolecules by phenobarbitone pretreatment. Biochemical Pharmacology 1975; 24: 11553–1556
   Google Scholar
• Gurtoo H. L., Dahms R. P. Effects of inducers and inhibitors on the metabolism of aflatoxin B1 by rat and mouse. Molecular Pharmacology 1979; 28: 3441–3449
   Google Scholar
• Gurtoo H. L., Dave C. V. In vitro metabolic conversion of aflatoxins and benzo(a)pyrene to nucleic acid-binding metabolites. Cancer Research 1975; 35: 382–389
   PubMed Web of Science ®Google Scholar
• Gurtoo H. L., Koser P. L., Bansel S. K., Fox H. W., Sharma S. D., Mulhern A. I., Pavelic Z. P. Inhibition of aflatoxin B1-hepatocarcinogenesis in rats by beta-naphthoflavone. Carcinogensis 1985; 6: 675–678
   PubMed Web of Science ®Google Scholar
• Habig W. H., Pabst M. J., Jakoby W. B. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 1974; 249: 7130–7139
   PubMed Web of Science ®Google Scholar
• Hales B. F., Neims A. H. Induction of rat hepatic glutathione S-transferase B by phenobarbital and 3-methylcholanthrene. Biochemical Pharmacology 1977; 26: 555–556
   PubMed Web of Science ®Google Scholar
• Hsieh D. P. H., Wong J. J. Metabolism and toxicity of aflatoxins. Advances in Experimental Biology and Medicine 1981; 136(pt B)847–863
   PubMedGoogle Scholar
• Jollow D. L., Mitchell J. R., Zamplaglione N., Gillette J. R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974; 11: 151–169
   PubMed Web of Science ®Google Scholar
• Labarca C., Paigen K. A simple, rapid and sensitive DNA assay procedure. Analytical Biochemistry 1980; 102: 344–352
   PubMed Web of Science ®Google Scholar
• Fundamentals of Drug Metabolism and Drug Disposition, B. N. LaDu, H. G. Mandel, E. L. Way. Williams and Wilkins, Baltimore, MD 1971; 569–572
   Google Scholar
• Lotlikar P. D., Insetta S. M., Lyons P. R., Jhee E. C. Inhibition of microsome-mediated binding of aflatoxin B1 to DNA by glutathione S-transferase. Cancer Letters 1980; 9: 143–149
   PubMed Web of Science ®Google Scholar
• Lotlikar P. D., Jhee E. C., Insetta S. M., Clearfield M. S. Modulation of microsomemediated aflatoxin B1 binding to exogenous and endogenous DNA by cytosolic glutathione S-transferases in rat and hamster livers. Carcinogenesis 1984a; 5: 269–276
   PubMed Web of Science ®Google Scholar
• Lotlikar P. D., Clearfield M. S., Jhee E. C. Effect of butylated hydroxyanisole on in vivo and in vitro aflatoxin B1-DNA binding in rats. Cancer Letter 1984b; 24: 241–250
   PubMed Web of Science ®Google Scholar
• Loury D. J., Hsieh D. P. H., Byard J. L. The effect of phenobarbital pretreatment on the metabolism, covalent binding and cytotoxicity of aflatoxin B1 in primary cultures of rat hepatocytes. Journal of Toxicology and Environmental Health, 13: 145–159
   PubMedGoogle Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol agent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Lutz W. K. In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutation Research 1979; 65: 289–356
   PubMed Web of Science ®Google Scholar
• Lutz W. K., Jaggi W., Luthy J., Sagelsdroff P., Schlatter C. In vivo covalent binding of aflatoxin B1 and aflatoxin M1 to liver DNA of rat, mouse and pig. Chemico-Biological Interactions 1980; 32: 249–256
   PubMed Web of Science ®Google Scholar
• Mclean A. E. M., Marshall A. Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone. British Journal of Experimental Pathology 1971; 52: 322–329
   Web of Science ®Google Scholar
• Metcalfe S. A., Colley P. J., Neal G. E. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes, in vitro. Chemico-Biological Interactions 1981; 35: 145–157
   PubMed Web of Science ®Google Scholar
• Mgbodile M. U. K., Holscher M., Neal R. A. A possible protective role for reduced glutathione in aflatoxin B1 toxicity: effect of pretreatment of rats with phenobarbical and 3-methylcholanthrene on aflatoxin toxicity. Toxicology and Applied Pharmacology 1975; 34: 128–142
   PubMed Web of Science ®Google Scholar
• Moss E. J., Judah D. J., Przybylski M., Neal G. E. Some mass-spectral and n.m.r. analytical studies of a glutathione conjugate of aflatoxin B1. Biochemical Journal 1983; 210: 227–233
   PubMed Web of Science ®Google Scholar
• Moss E. J., Manson M. M., Neal G. E. Effect of manipulation of gamma-glutamyl transpeptidase levels on biliary excretion of aflatoxin B1 gamma-glutamyl transpeptidase levels on biliary excretion of aflatoxin B1 conjugates. Carcinogenesis 1984; 5: 869–874
   PubMedGoogle Scholar
• Neal G. E., Godoy H. M. The effect of pre-treatment with phenobarbitone on the activation of aflatoxin B1 by rat liver. Chemico-Biological Interactions 1976; 14: 279–289
   PubMed Web of Science ®Google Scholar
• Neal G. E., Green J. A. The requirement for glutathione S-transferase in the conjugation of activated aflatoxin B1 during aflatoxin hepatocarcinogenesis in the rat. Chemico-Biological Interactions 1983; 45: 259–275
   PubMed Web of Science ®Google Scholar
• Oesch F., Jerina D. M., Daly J. A radiometric assay for hepatic epoxide hydrase activity with 7-3H-styrene oxide. Biochimica et Biophysica Acta 1971; 227: 685–691
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Salocks C. B., Hsieh D. P. H., Byard J. L. Butylated hydroxytoluene pretreatment protects against cytotoxicity and reduces covalent binding of aflatoxin B1 in primary hepatocyte cultures. Toxicology and Applied Pharmacology 1981; 59: 331–345
   PubMedGoogle Scholar
• Tavoloni N., Wittman R., Jones M. T., Berk P. D. Effect of low-dose phenobarbital on hepatic microsomal UDP-glucuronyl transferase activity. Biochemical Pharmacology 1983; 32: 2143–2147
   PubMedGoogle Scholar
• Thompson T. N., Watkins J. B., Gregus Z., Klaassen C. D. Effect of microsomal enzyme inducers on the soluble enzymes of hepatic phase II biotransformation. Toxicology and Applied Pharmacology 1982; 66: 400–408
   PubMed Web of Science ®Google Scholar
• Viviani A., Lutz W. K. Modulation of the binding of the carcinogen benzo(a)pyrene to rat liver DNA in vivo by selective induction of microsomal and nuclear aryl hydrocarbon hydroxylase activity. Cancer Research 1978; 38: 4640–4644
   PubMed Web of Science ®Google Scholar
• Westkaemper R. B., Hanzlik R. P. A convenient reverse-phase liquid chromatographic assay for epoxide hydrase. Analytical Biochemistry 1980; 102: 63–67
   PubMed Web of Science ®Google Scholar
• Wogan G. N., Edwards G. S., Shank R. C. Excretion and tissue distribution of radioactivity from aflatoxin B1- 14C in rats. Cancer Research 1967; 27: 1729–1736
   PubMedGoogle Scholar
• Wong Z. A., Hsieh D. P. H. The comparative metabolism and toxicokinetics of aflatoxin B1 in the monkey, rat, and mouse. Toxicology and Applied Pharmacology 1980; 55: 115–125
   PubMed Web of Science ®Google Scholar
• Wong Z. A., Wei C. -I., Rice D. W., Hsieh D. P. H. Effects of phenobarbital pretreatment on the metabolism and toxicokinetics of aflatoxin B1 in the rhesus monkey. Toxicology and Applied Pharmacology 1981; 60: 387–397
   PubMedGoogle Scholar